Related Experiment Video
Updated: Nov 18, 2025
07:50
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
598
Cancer Trends in Iraq 2000-2016
Ashraf Ma Hussain1, Riyadh K Lafta2,3
1Department of Family and Community Medicine, College of Medicine, University of Babylon, Babil, Iraq.
Oman Medical Journal
|February 8, 2021
Summary
Cancer incidence in Iraq is rising, particularly for lung and gastrointestinal cancers after 2007. Most cancer types predominantly affect males, with only cervical and laryngeal cancers showing a decrease.
Area of Science:
- Public Health
- Epidemiology
- Oncology
Background:
- Accurate cancer burden assessment is crucial for resource allocation and policy development.
- Understanding cancer trends helps in evaluating the impact of control measures.
- This study focuses on cancer trends in Iraq from 2000 onwards.
Purpose of the Study:
- To evaluate the trends of childhood and adult cancers in Iraq.
- To identify specific cancer types with increasing or decreasing incidence rates.
- To analyze cancer trends by age, gender, and geographical distribution.
Main Methods:
- Utilized data from the Iraqi Ministry of Health registries (2000-2016).
- Analyzed cancer incidence rates across all governorates.
- Stratified data by age, gender, and governorate to depict trends.
Main Results:
- Breast cancer incidence significantly increased, predominantly in females.
- Lung cancer rates rose significantly (4.08 to 5.60/100,000), affecting males more.
- Stomach and colorectal cancer trends accelerated post-2007; brain cancer showed no significant trend change.
Conclusions:
- Most cancers, especially lung and gastrointestinal, exhibit a consistent upward trend since 2007.
- Cervical and laryngeal cancers are the only types showing a decreasing trend.
- The majority of cancer types analyzed were more prevalent in males.
More Related Videos
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.7K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.9K
Related Concept Videos
01:21Cancer Survival Analysis
525
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
525
02:21Cancers Originate from Somatic Mutations in a Single Cell
13.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.5K
02:18Cancer
52.0K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
52.0K
02:49Cancer Therapies
9.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.1K
02:07Tumor Progression
6.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
03:03mTOR Signaling and Cancer Progression
4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.1K